Abstract
OBJECTIVE: To measure the impact of a teaching intervention and to compare process and outcomes of care for HIV-infected patients randomly assigned to a general medicine clinic (GMC) or an infectious disease clinic (IDC) for primary care.
DESIGN: Prospective, randomized, controlled trial.
SETTING: University hospital in Durham, NC.
PATIENTS: Two hundred fourteen consecutive HIV-infected patients presenting for primary care.
INTERVENTION: Physicians at the GMC received HIV-related training and evidence-based practice guidelines.
MEASUREMENTS: Utilization of services, health-related quality of life, preventive and screening measures, and antiretroviral use for one year.
RESULTS: At baseline GMC patients were more likely to be African American (85% vs 71%; P=.03) and had lower baseline CD4+ cell counts than IDC patients (262±269 vs 329±275; P=.05). A similar and high proportion of patients in both groups received appropriate preventive care services including Pneumocystis carinii pneumonia (PCP) prophylaxis, pneumococcal vaccination, and antiretroviral therapy. Screening for TB was more frequent in GMC (89% vs 68%; P=.001). In the year following randomization, GMC patients made more visits to the emergency department than IDC patients (1.6±3.0 vs 0.7±1.5; P=.05). Hospital use was higher for GMC patients with average length of stay 7.8±6.3 days compared to 5.7±3.8 days for IDC patients (P=.01). In analyses, which adjust for potential baseline imbalances, these differences remained.
CONCLUSIONS: Targeted education in GMC achieved similar provision of primary care for GMC patients, yet use of health care services was higher for this group. The delivery of adequate primary care is necessary but not sufficient to produce changes in health care utilization.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Turner BJ, McKee L, Fanning T, Markson LE. AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use. Med Care. 1994;32:902–16.
Markson LE, Cosler LE, Turner BJ. Implications of generalists’ slow adoption of zidovudine in clinical practice. Arch Intern Med. 1994;154:1497–504.
Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians’ experience with the acquired immunodeficiency syndrome as a factor in patients’ survival. N Engl J Med. 1996;334:701–6.
Hayward RA, Kravitz RL, Shapiro MF. Program directors’ attitudes towards residents’ care of patients who have AIDS. J Gen Intern Med. 1991;6:18–26.
Hayward RA, Weissfeld JL. Coming to terms with the era of AIDS: attitudes of physicians in U.S. residency programs. J Gen Intern Med. 1993;8:10–8.
Shapiro MF, Hayward RA, Guillemot D, Jayle D. Residents’ experiences in, and attitudes toward, the care of persons with AIDS in Canada, France, and the United States. JAMA. 1992;268:510–5.
Wu AW. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29:786–98.
Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care. 1998;36:126–37.
Anonymous. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morb Mortal Wkly Rep. 1992;41(RR–4):1–11.
Anonymous. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Clin Infect Dis. 1997;25(Suppl 3):313–5.
Anonymous. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Clin Infect Dis. 1995;21(Suppl 1):32–43.
Anonymous. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Ann Intern Med. 1997;127:922–46.
Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS. 1999;13:963–9.
Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA. AIDS. 1997;11:F101-F105.
Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census [letter]. N Engl J Med. 1997;336:1531–2.
Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998;339:1897–904.
Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281:2305–15.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a grant from the Robert Wood Johnson Foundation and the Lawrence S. Linn Foundation for the study of quality of life in HIV-infected patients.
Rights and permissions
About this article
Cite this article
Keitz, S.A., Box, T.L., Homan, R.K. et al. Primary care for patients infected with human immunodeficiency virus. J GEN INTERN MED 16, 573–582 (2001). https://doi.org/10.1046/j.1525-1497.2001.016009573.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2001.016009573.x